Search results
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 10 hours agoWith many pharma and biotech bigwigs having already reported results, the earnings picture has been...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WSLS Newschannel 10 Roanoke· 8 hours agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
AstraZeneca beats revenue, profit estimates on resilient demand
Reuters· 6 days agoAstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg· 6 days agoAstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu.
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press via Yahoo News· 8 hours agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
AstraZeneca's £18.7m boss Soriot bounces back as pharma giant reveals 18% sales growth
Evening Standard via Yahoo Finance· 6 days agoThe top-paid boss on the FTSE 100, AstraZeneca’s Pascal Soriot, bounced back today from the row over...
FTSE 100 Live: Index hits record; Anglo American jumps on BHP bid
Proactive Investors· 6 days agoAstraZeneca PLC (LSE:AZN)’s 5.7% climb following Thursday’s first-quarter earnings print has made...
FTC Targets ‘Junk’ Patent Listings on Ozempic and Other Drugs
The Wall Street Journal· 3 hours agoThe letters targeted what agency officials called “junk listings” on patents for 20 drug products,...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
WPXI· 8 hours agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Top 4 Health Care Stocks That May Plunge This Month - AstraZeneca (NASDAQ:AZN), Boston Scientific...
Benzinga· 5 days agoAs of April 26, 2024, four stocks in the health care sector could be flashing a real warning to...